Trial Information
Inclusion Criteria:
- Ability and willingness to provide written informed consent
- Must be between 18-90 years of age at the time of consent
- Ability to provide urine specimen at protocol-defined timepoints
- Must have treatment interventions planned that are directly related to liver disease
(excluding those assigned to group 3-Controls)
Exclusion Criteria:
- Suspected inability, e.g. unwillingness to comply with study procedures or
unwillingness to provide written consent
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Cross-Sectional
Authority:
United States: Institutional Review Board
Study ID:
Urinary Biomarkers 101423
NCT ID:
NCT01316679
Start Date:
March 2011
Completion Date:
April 2014
Related Keywords:
- Hepatocellular Carcinoma
- Liver Disease
- HCC
- Liver Disease without HCC
- Carcinoma
- Liver Diseases
- Carcinoma, Hepatocellular